Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The Yield and Safety of Skin Biopsies in Acute Myeloid Leukemia Patients during Intensive Chemotherapy Treatment

Tamar Berger, MD, Ofir Wolach, MD, Shany Sherman, MD, Adi Shacham Abulafia, MD, Pia Raanani, MD, Oren Pasvolsky, MD

Blood (2019) 134 (Supplement_1): 5110.

https://doi.org/10.1182/blood-2019-125133

Published: 2019

Journal Articles

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Holly Lee, MD, Lesley Street, MD, Jason Tay, MD, Jennifer Grossman, MD, John F Thaell, MD, Dawn Goodyear, MD, Sylvia McCulloch, MD, Peter Duggan, MD, Paola Neri, MD, Victor Jimenez-Zepeda, MD

Blood (2018) 132 (Supplement 1): 4495.

https://doi.org/10.1182/blood-2018-99-117819

Published: 2018

Journal Articles

Ptpn6 Inhibits IL-1 Release from Neutrophils By Regulation of Caspase-8- and Ripk3/Mlkl-Dependent Forms of Cell Death

Mary Speir, PhD, Joanne A O'Donnell, PhD, Alyce A Chen, PhD, Akshay A D'Cruz, PhD, Ben A Croker, PhD

Blood (2018) 132 (Supplement 1): 274.

https://doi.org/10.1182/blood-2018-99-120197

Published: 2018

Journal Articles

Peg-Filgrastim for the Treatment of Severe Chronic Neutropenia

Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Laurence A. Boxer, MD, Peter E. Newburger, MD, Mary Ann Bonilla, MD, David C. Dale, MD

Blood (2016) 128 (22): 1332.

https://doi.org/10.1182/blood.V128.22.1332.1332

Published: 2016

Journal Articles

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

Vincent Jachiet, Eric Grignano, Arsène Mekinian, Paul Coppo, MD PhD, Olivier Fain

Blood (2016) 128 (22): 5335.

https://doi.org/10.1182/blood.V128.22.5335.5335

Published: 2016

Journal Articles

The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2546.

https://doi.org/10.1182/blood.V126.23.2546.2546

Published: 2015

Journal Articles

Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Blood (2015) 126 (23): 1695.

https://doi.org/10.1182/blood.V126.23.1695.1695

Published: 2015

Journal Articles

NLRP3 Inflammosome Polymorphisms Are Enriched in Myelodysplastic Syndrome Patients with Autoimmune Disorders

Syed A Mian, BSc, M.Phil, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Aytug Kizilors, PhD, Kathy L McGraw, PhD, Shahram Kordasti, MD PhD, Stephan Menzel, PhD, Alexander e Smith, PhD, Pilar Perezabellan, BSc, David Sallman, MD, Alan F. List, MD, Ghulam J Mufti, FRCP, FRCPath

Blood (2015) 126 (23): 1659.

https://doi.org/10.1182/blood.V126.23.1659.1659

Published: 2015

Journal Articles

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

Yasunobu Takeoka, Akiko Miura, Koji Nakamura, Junko Nakamura, Ryosuke Yamamura, MD PhD, Taku Araki, Hirohisa Nakamae, Masayuki Hino, Prof., Kensuke Ohta, MD PhD

Blood (2014) 124 (21): 3256.

https://doi.org/10.1182/blood.V124.21.3256.3256

Published: 2014

Journal Articles

Chronic Relapsing Remitting Sweet’s Syndrome- a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients

Austin G Kulasekararaj, Shahram Y Kordasti, Tanya Basu, Jon Salisbury, Anthony du Vivier, Ghulam J. Mufti, MD, PhD

Blood (2013) 122 (21): 2793.

https://doi.org/10.1182/blood.V122.21.2793.2793

Published: 2013

Journal Articles

Cytogenetic and Molecular Characterization of Sweet's Syndrome in Patients with Acute Myeloid Leukemia.

Syed M. Kazmi, MD, Hagop M. Kantarjian, MD, Kathy M. Tran, Jorge E. Cortes, MD, Farhad Ravandi, MD, Gautam Borthakur, M.D., Elias J. Jabbour, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, M.D., Naval Daver, MD, Sherry A. Pierce, RN, BS, Aziz Nazha, Alfonso Quintas-Cardama, MD, Naveen Pemmaraju, M.D.

Blood (2012) 120 (21): 2587.

https://doi.org/10.1182/blood.V120.21.2587.2587

Published: 2012

Journal Articles

Evidence of Differentiation in Myeloid Malignancies Associated Neutrophilic Dermatosis

Pierre Sujobert, Wendy Cuccuini, Herve Dombret, Marie-Dominique Vignon-Pennamen, Emmanuel Raffoux, MD, PhD

Blood (2011) 118 (21): 2566.

https://doi.org/10.1182/blood.V118.21.2566.2566

Published: 2011

Journal Articles

The Response of FLT3/ITD AML to FLT3 Inhibition: Apoptosis of Peripheral Blood Blasts and Differentiation of Bone Marrow Blasts

Amy Sexauer, Xiaochuan Yang, PhD, Alexander E Perl, MD, Christian Thiede, MD, Michael J. Borowitz, MD, PhD, Mark J. Levis, MD, PhD

Blood (2011) 118 (21): 943.

https://doi.org/10.1182/blood.V118.21.943.943

Published: 2011

Journal Articles

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Tetsuya Tanimoto, MD, Yasuo Oshima, MD, PhD, FACP, Koichiro Yuji, M.D., Ph.D., Masahiro Kami, MD, PhD

Blood (2011) 118 (21): 1698.

https://doi.org/10.1182/blood.V118.21.1698.1698

Published: 2011

Journal Articles

Terminal Differentiation of FLT3/ITD AML Blasts In Patients Treated with the FLT3 Inhibitor AC220

Mark J. Levis, MD, PhD, Amy Sexauer, Trivikram Rajkhowa, Donald Small, MD, PhD, Michael J. Borowitz, MD, PhD

Blood (2010) 116 (21): 660.

https://doi.org/10.1182/blood.V116.21.660.660

Published: 2010

Journal Articles

Pleural Effusions Associated with Use of Dasatinib in Chronic Myeloid Leukemia May Have an Auto-Immune Pathogenesis.

Sinthiya Punnialingam, Hugues de Lavallade, MD, Dragana Milojkovic, MD, Bua Marco, MD, Jamshid S. Khorashad, MD, John M. Goldman, DM, Jane F. Apperley, MD, David Marin, MD

Blood (2007) 110 (11): 2945.

https://doi.org/10.1182/blood.V110.11.2945.2945

Published: 2007

Journal Articles

Predictive Factors of All Trans-Retinoic Acid (ATRA) Related Complications during Induction Course of Acute Promyelocytic Leukemia (APL).

Jeddi Ramzi, Kacem Karima, Benneji Hend, Mnif Samia, Belakhal Raihane, Aissaoui Lamia, Benabid Hela, Belhadjali Zaher, Meddeb Balkis

Blood (2006) 108 (11): 4544.

https://doi.org/10.1182/blood.V108.11.4544.4544

Published: 2006

Journal Articles

Sweet’s Syndrome: A Frequently Unrecognized Complication Following Acute Myeloid Leukemia (Aml) Induction Chemotherapy: A Case Report.

Toru Okura, MD, David M. Aboulafia, MD, Vincent Picozzi, MD

Blood (2006) 108 (11): 4547.

https://doi.org/10.1182/blood.V108.11.4547.4547

Published: 2006

Journal Articles

Bortezomid-Induced Sweet Syndrome.

Aline A. Schmidt-Tanguy, MD, Martine M. Avenel-Audran, MD, Séverine S. Lissandre, MD, Mammoun M. Dib, MD, Anne A. Croue, MD, Marie-Pierre M.P. Moles, MD, Norbert N. Ifrah, MD PhD, Mathilde M. Hunault-Berger, MD PhD

Blood (2006) 108 (11): 5128.

https://doi.org/10.1182/blood.V108.11.5128.5128

Published: 2006

Journal Articles

NCI Fanconi’s Anemia Cohort: Hematology and Beyond.

Neelam Giri, MD, Dalia Batista, MD, Constantine Stratakis, MD, Ekaterini T. Tsilou, MD, Hung J. Kim, MD, Blanche P. Alter, MD, MPH

Blood (2005) 106 (11): 1057.

https://doi.org/10.1182/blood.V106.11.1057.1057

Published: 2005

NARROW

The Yield and Safety of Skin Biopsies in Acute Myeloid Leukemia Patients during Intensive Chemotherapy Treatment

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Ptpn6 Inhibits IL-1 Release from Neutrophils By Regulation of Caspase-8- and Ripk3/Mlkl-Dependent Forms of Cell Death

Peg-Filgrastim for the Treatment of Severe Chronic Neutropenia

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia

Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

NLRP3 Inflammosome Polymorphisms Are Enriched in Myelodysplastic Syndrome Patients with Autoimmune Disorders

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

Chronic Relapsing Remitting Sweet’s Syndrome- a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients

Cytogenetic and Molecular Characterization of Sweet's Syndrome in Patients with Acute Myeloid Leukemia.

Evidence of Differentiation in Myeloid Malignancies Associated Neutrophilic Dermatosis

The Response of FLT3/ITD AML to FLT3 Inhibition: Apoptosis of Peripheral Blood Blasts and Differentiation of Bone Marrow Blasts

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Terminal Differentiation of FLT3/ITD AML Blasts In Patients Treated with the FLT3 Inhibitor AC220

Pleural Effusions Associated with Use of Dasatinib in Chronic Myeloid Leukemia May Have an Auto-Immune Pathogenesis.

Predictive Factors of All Trans-Retinoic Acid (ATRA) Related Complications during Induction Course of Acute Promyelocytic Leukemia (APL).

Sweet’s Syndrome: A Frequently Unrecognized Complication Following Acute Myeloid Leukemia (Aml) Induction Chemotherapy: A Case Report.

Bortezomid-Induced Sweet Syndrome.

NCI Fanconi’s Anemia Cohort: Hematology and Beyond.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only